menu
    • menu

    Company profile for BioNTech

    NEW Drugs in Dev: 63
    European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

    Virtual Booth

    Contact Supplier

    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    USP reference standards; highly characterized specimens of drug substances, impurities, excipients, degradation products & more.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

    Virtual Booth

    Contact Supplier

    Guizhou Utide Biotechnology Co., Ltd. - Specialized GMP manufacturing for next-generation GLP-1 peptide APIs.

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    BioNTech SE is Europe’s largest privately held biopharmaceutical company pioneering the development of individualized therapies for cancer and other diseases. The Company combines all of the building blocks of individualized immunotherapy under one roof – from diagnostics and drug development to manufacturing. Its cutting-edge technologies range from individualized mRNA-based medicines through innovative chimeric antigen ...
    BioNTech SE is Europe’s largest privately held biopharmaceutical company pioneering the development of individualized therapies for cancer and other diseases. The Company combines all of the building blocks of individualized immunotherapy under one roof – from diagnostics and drug development to manufacturing. Its cutting-edge technologies range from individualized mRNA-based medicines through innovative chimeric antigen receptors and T-cell receptor-based products to novel checkpoint immunomodulators.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    BioNTechGermany Flag
    Country
    Country
    Germany
    Address
    Address
    An der Goldgrube 12 D-55131 Mainz
    Telephone
    Telephone
    +49-6131-9084-0
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.biontech.com/int/en/home.html
    Linkedin
    Linkedin
    https://www.linkedin.com/company/biontech-ag
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/biontech_group?lang=en

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    ChemTides

    Not Confirmed

    envelop Contact Supplier

    ChemTides

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    BioNTech Founders To Leave Famed mRNA Biotech For New Venture
    BioNTech Founders To Leave Famed mRNA Biotech For New Venture

    11 Mar 2026

    // BIOSPACE

    https://www.biospace.com/business/biontech-founders-to-leave-famed-mrna-biotech-for-new-venture

    BIOSPACE
    11 Mar 2026
    Share Share
    Biontech's CEO, CMO Will Depart To Set Up Next-Gen mRNA Company
    Biontech's CEO, CMO Will Depart To Set Up Next-Gen mRNA Company

    10 Mar 2026

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/biontechs-ceo-cmo-prep-departure-set-next-gen-mrna-company

    FIERCE BIOTECH
    10 Mar 2026
    Share Share
    Biontech Reveals 2025 Financials And Corporate Update
    Biontech Reveals 2025 Financials And Corporate Update

    10 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/10/3252585/0/en/BioNTech-Announces-Fourth-Quarter-and-Full-Year-2025-Financial-Results-and-Corporate-Update.html

    GLOBENEWSWIRE
    10 Mar 2026
    Share Share
    BioNTech To Present Q4 2025 Financials And Corporate Update
    BioNTech To Present Q4 2025 Financials And Corporate Update

    24 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/24/3243320/0/en/BioNTech-to-Report-Fourth-Quarter-and-Full-Year-2025-Financial-Results-and-Corporate-Update-on-March-10-2026.html

    GLOBENEWSWIRE
    24 Feb 2026
    Share Share
    BioNTech Sues Moderna For Patent Infringement Over COVID Shot
    BioNTech Sues Moderna For Patent Infringement Over COVID Shot

    20 Feb 2026

    // REUTERS

    https://www.reuters.com/world/biontech-sues-moderna-patent-infringement-over-covid-19-shots-2026-02-19/

    REUTERS
    20 Feb 2026
    Share Share
    BioNTech Leads With Diverse Pipeline Over Moderna's mRNA Focus
    BioNTech Leads With Diverse Pipeline Over Moderna's mRNA Focus

    03 Feb 2026

    // BIOSPACE

    https://www.biospace.com/business/biontechs-multi-modality-play-outpaces-modernas-mrna-focused-pipeline

    BIOSPACE
    03 Feb 2026
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search